Immune responses and clinical outcomes in STAND, a randomized phase 2 study evaluating optimal sequencing of sipuleucel-T (sip-T) and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC) after local therapy failure. Academic Article

authors

  • Antonarakis, Emmanuel S.
  • Kibel, Adam S.
  • Adams, George W.
  • Karsh, Lawrence, MD, FACS, CPI
  • Elfiky, Aymen
  • Shore, Neal D.
  • Vogelzang, Nicholas J.
  • Corman, John M.
  • Maher, Johnathan Cartwright
  • DeVries, Todd
  • McCoy, Candice
  • Sheikh, Nadeem A.
  • Drake, Charles G.

Publication Date

  • 2015

webpage

published in

Digital Object Identifier (DOI)

number of pages

  • 1

start page

  • 5030

end page

  • 5030

volume

  • 33

issue

  • 15_suppl